- Home
- CNTA vs SPNT Comparison
CNTA vs SPNT Comparison
Compare CNTA & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- SPNT
- Stock Information
- Founded
- CNTA 2020
- SPNT 2011
- Country
- CNTA United Kingdom
- SPNT Bermuda
- Employees
- CNTA N/A
- SPNT N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- SPNT Property-Casualty Insurers
- Sector
- CNTA Health Care
- SPNT Finance
- Exchange
- CNTA Nasdaq
- SPNT Nasdaq
- Market Cap
- CNTA 2.3B
- SPNT 2.2B
- IPO Year
- CNTA 2021
- SPNT N/A
- Fundamental
- Price
- CNTA $22.97
- SPNT $18.02
- Analyst Decision
- CNTA Strong Buy
- SPNT Buy
- Analyst Count
- CNTA 11
- SPNT 3
- Target Price
- CNTA $30.60
- SPNT $24.00
- AVG Volume (30 Days)
- CNTA 1.5M
- SPNT 1.0M
- Earning Date
- CNTA 11-11-2025
- SPNT 10-30-2025
- Dividend Yield
- CNTA N/A
- SPNT N/A
- EPS Growth
- CNTA N/A
- SPNT N/A
- EPS
- CNTA N/A
- SPNT 0.75
- Revenue
- CNTA $15,000,000.00
- SPNT $2,793,700,000.00
- Revenue This Year
- CNTA N/A
- SPNT N/A
- Revenue Next Year
- CNTA N/A
- SPNT $6.45
- P/E Ratio
- CNTA N/A
- SPNT $23.91
- Revenue Growth
- CNTA 118.88
- SPNT 3.57
- 52 Week Low
- CNTA $9.60
- SPNT $12.78
- 52 Week High
- CNTA $23.24
- SPNT $21.03
- Technical
- Relative Strength Index (RSI)
- CNTA 71.96
- SPNT 39.84
- Support Level
- CNTA $20.94
- SPNT $17.90
- Resistance Level
- CNTA $23.24
- SPNT $19.30
- Average True Range (ATR)
- CNTA 1.39
- SPNT 0.45
- MACD
- CNTA 0.41
- SPNT -0.08
- Stochastic Oscillator
- CNTA 96.72
- SPNT 7.89
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.